Release Therapeutics

Geneva, Switzerland

Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.

$3.9M raised

Aug 2024

Seed

Biotechnology Medical Device

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Release Therapeutics

How much funding has Release Therapeutics raised?

Release Therapeutics has raised $3.9M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Where is Release Therapeutics headquartered?

Release Therapeutics is headquartered in Geneva, Switzerland.

What does Release Therapeutics do?

Release Therapeutics is a private BioMedTech company on a mission to treat genetic diseases of the CNS without gene therapy.

What stage is Release Therapeutics at?

Release Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 6, 2024.

MLA

"Release Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/release-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Release Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/release-therapeutics

Wikipedia (cite web)

{{cite web |title=Release Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/release-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 6, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K